BioMarin Pharmaceutical Inc (BMRN): Cash & Equivalents
$1.31B
As of 2025-12-31
$874.00M
As of 2026-06-30
+21.9%
3-year compound annual growth
+15.1%
5-year compound annual growth
+12.7%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.31B | +39.1% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $942.84M | +24.9% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $755.13M | +4.2% | 2025-02-24, Balance as of period end |
| 2022-12-31 | $724.53M | +23.4% | 2024-02-26, Balance as of period end |
| 2021-12-31 | $587.28M | -9.5% | 2023-02-27, Balance as of period end |
| 2020-12-31 | $649.16M | +48.4% | 2022-02-25, Balance as of period end |
| 2019-12-31 | $437.45M | -11.4% | 2021-02-26, Balance as of period end |
| 2018-12-31 | $493.98M | -17.4% | 2020-02-27, Balance as of period end |
| 2017-12-31 | $598.03M | +46.5% | 2019-02-28, Balance as of period end |
| 2016-12-31 | $408.33M | +2.8% | 2019-02-28, Balance as of period end |
| 2015-12-31 | $397.04M | -54.6% | 2018-02-26, Balance as of period end |
| 2014-12-31 | $875.49M | +53.9% | 2017-02-27, Balance as of period end |
| 2013-12-31 | $568.78M | +215.1% | 2016-02-29, Balance as of period end |
| 2012-12-31 | $180.53M | +290.1% | 2015-03-02, Balance as of period end |
| 2011-12-31 | $46.27M | -47.5% | 2014-02-26, Balance as of period end |
| 2010-12-31 | $88.08M | -47.3% | 2013-02-26, Balance as of period end |
| 2009-12-31 | $167.17M | -25.0% | 2012-02-22, Balance as of period end |
| 2008-12-31 | $222.90M | n/a | 2011-02-24, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $1.31B | +39.1% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $1.56B | -8.3% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $282.03M | +155.1% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $1.66B | +71.5% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $1.39B | -42.3% |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $618.70M | -33.4% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $545.00M | +16.5% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $801.28M | -27.4% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $4.55B | +73.1% |
Compare BMRN, UTHR, AMRX, ALNY side by side · Screen every company in Pharmaceutical Preparations ↗